Jazz PharmaceuticalsJAZZ

• Phase ?에피디올렉스(대마 성분약) 만성 간 손상 위험 평가진행 중Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
  38%
• Phase 3특정 유전자 변이 뇌종양 대상 방사선 후 ONC201 치료 임상모집 중ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
  33%
• Phase 2JZP3507 재발성 2·3등급 뇌수막종 치료 임상시작 전A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
  58%
• Phase ?결절성 경화증 환자 대상 Epidiolex 병용 치료 임상진행 중A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex
  51%
• Phase 1변이 고형암 경구용 표적치료제 JZP815 1상 임상모집 중A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815
  72%
• Phase 2ONC206 진행성 갈색세포종·부신경절종 치료 임상모집 중Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma
  62%
• Phase ?Epidyolex 소아 희귀 뇌전증 치료 효과 관찰연구모집 중Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY
  80%
• Phase 3전이성 HER2 양성 유방암 대상 자니다타맙 비교 임상모집 중A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
  74%
• Phase 1루르비넥테딘 난치성 소아 유윙육종 단독치료 임상모집 중Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
  47%
• Phase 1JZP047 건강인 대상 안전성 및 음식 영향 평가시작 전A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of JZP047 in Healthy Participants
  76%
• Phase 1JZP898 진행성 고형암 키트루다 병용 임상모집 중JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
  72%
• Phase ?에피디올렉스 임신 중 복용 안전성 추적 조사모집 중Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
  59%

성공 확률은 BERA의 AI 모델(임상 설계·약물 구조·과거 사례 기반)이 계산한 값이에요. 실제 결과와 다를 수 있어요.